The Innovative Health Initiative (IHI) has launched two new calls for proposals, IHI calls 6 and 7, addressing a wide range of challenges in health research and innovation.
IHI call 6 is a two-stage call with topics on treatment persistency in chronic diseases and the development of guidance on the use of real-world data and evidence. Deadline for short proposals: 16 April 2024
IHI call 7 is a single-stage call with topics on heart disease management, the sustainability of the hospital workforce, and biomarker validation. Deadline for full proposals: 22 May 2024
IHI welcomes Niklas Blomberg as new Executive Director
Niklas Blomberg has roots both in the pharma industry & in academic research. Joining IHI is the ‘two major strands of my career coming together’ he says in an interview with the IHI office.
Clinical trial for TB drug regimens launched by IMI project UNITE4TB
The trial will test 14 combinations of 9 existing drugs plus 2 candidate drugs, with the goal of identifying the right combination of drugs and the shortest possible treatment duration.
Game-changing trial for children with tumours being established thanks to IMI project EU-PEARL
The Children’s Tumor Foundation and the Global Coalition for Adaptive Research are making EU-PEARL’s model for a platform trial for patients with neurofibromatosis-1 and schwannomatosis into a reality.
How well does a flu vaccine work? DRIVE evaluates performance
IMI project DRIVE successfully tested how well various brands of flu vaccines worked across five European countries and a range of age groups, and published their results in Frontiers Public Health.
Heart disease care to get personal thanks to new IHI project iCARE4CVD
iCARE4CVD aims to facilitate a more personalised approach to cardiovascular disease care, from identifying those at risk right through to caring for people with advanced disease.
